| Q40072508 | A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. |
| Q35956960 | Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. |
| Q36099097 | Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication |
| Q39550597 | Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth |
| Q39685724 | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus |
| Q34434777 | Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus |
| Q39642417 | Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. |
| Q34977139 | Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model |
| Q37033241 | Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry |
| Q43161154 | Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts |
| Q37596465 | Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells |
| Q90714289 | Duck plague virus gE serves essential functions during the virion final envelopment through influence capsids budding into the cytoplasmic vesicles |
| Q30832346 | Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection |
| Q35101360 | Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection |
| Q39601211 | Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument |
| Q41482036 | Felid herpesvirus type 1 infection in cats: a natural host model for alphaherpesvirus pathogenesis |
| Q37596576 | Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo |
| Q33591823 | Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection |
| Q40117236 | Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system |
| Q28474768 | Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor |
| Q37065966 | Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus. |
| Q40843597 | Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells |
| Q39753125 | Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells |
| Q39605251 | Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells |
| Q34499618 | Herpesvirus assembly and egress |
| Q24522734 | High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro |
| Q48172861 | In the absence of glycoprotein I (gI), gE determines bovine herpesvirus type 5 neuroinvasiveness and neurovirulence |
| Q40478161 | Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope |
| Q33622464 | Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability |
| Q37633252 | Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk |
| Q33639421 | Intracellular traffic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization. |
| Q36171893 | Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission |
| Q30531746 | Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo |
| Q33791387 | Molecular mechanisms of varicella zoster virus pathogenesis |
| Q35076854 | Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells |
| Q34977329 | Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo |
| Q33853728 | Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus |
| Q34434911 | Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region |
| Q33640129 | Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses |
| Q35139995 | ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo |
| Q35000306 | Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49. |
| Q39698466 | Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo |
| Q36890186 | Requirement of Varicella-Zoster Virus Immediate-Early 4 Protein for Viral Replication |
| Q39550665 | Retrograde, transneuronal spread of pseudorabies virus in defined neuronal circuitry of the rat brain is facilitated by gE mutations that reduce virulence. |
| Q39686119 | Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress |
| Q33724286 | Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo |
| Q35776521 | Simian varicella virus gene expression during acute and latent infection of rhesus macaques |
| Q34045556 | T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection |
| Q36327713 | The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse |
| Q35947774 | The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor |
| Q39580163 | The disulfide-bonded structure of feline herpesvirus glycoprotein I. |
| Q33987514 | The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors |
| Q33785316 | The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions |
| Q35543796 | The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. |
| Q33554456 | The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection |
| Q36145800 | The varicella-zoster virus genome |
| Q39592132 | Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain |
| Q39685893 | Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers |
| Q35054349 | Varicella zoster virus latency |
| Q39214502 | Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis |
| Q36474261 | Varicella-Zoster Virus ORF47 Protein Kinase, Which Is Required for Replication in Human T Cells, and ORF66 Protein Kinase, Which Is Expressed during Latency, Are Dispensable for Establishment of Latency |
| Q33833934 | Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model |
| Q33641265 | Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase |
| Q33828495 | Varicella-zoster virus T cell tropism and the pathogenesis of skin infection |
| Q34457924 | Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis |
| Q37336873 | Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures |
| Q33704274 | Varicella-zoster virus human ganglionic latency: a current summary |
| Q34545651 | Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo |
| Q28363307 | Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells |